Case Control Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Feb 21, 2019; 25(7): 837-847
Published online Feb 21, 2019. doi: 10.3748/wjg.v25.i7.837
Table 2 Baseline psycho-social and quality of life markers in control subjects and IBS patients
ControlIBSP value
Somatization10.4 ± 0.41.8 ± 1.10.001
Obsession10.3 ± 0.31.2 ± 0.70.004
Interpersonal sensitivity10.2 ± 0.30.7 ± 0.70.05
Depression10.3 ± 0.41.5 ± 1.30.01
Anxiety10.2 ± 0.31.1 ± 0.80.005
Hostility10.2 ± 0.20.5 ± 0.60.09
Phobic anxiety10.1 ± 0.20.8 ± 1.00.05
Paranoid ideation10.2 ± 0.20.6 ± 0.50.025
Psychoticism10.1 ± 0.20.5 ± 0.50.013
Positive global symptoms117.2 ± 13.346.0 ± 21.70.002
Distress index11.2 ± 0.21.9 ± 0.60.002
HAD anxiety3.6 ± 2.011.1 ± 4.80.000
HAD depression1.5 ± 1.56.7 ± 5.40.01
HAD score5.1 ± 2.617.8 ± 9.60.000
Physical score255.0 ± 5.037.4 ± 11.70.000
Mental score253.9 ± 6.042.3 ± 11.60.001